ms and glp 1 2024 Multiple Sclerosis Highlight The next 40 million GLP-1

[(accessed on 13 March 2024)];Lancet Diabetes Endocrinol

This reflects the massmarket scale of obesity and diabetes, where oral options could materially expand access, persistence, and earlier therapy initiation or continuation of treatment for patients moving from injectable to orals, Campbell said

Two reviewers independently conducted the quality assessments, and any discrepancies were resolved through discussion or consultation with a third reviewer (A.N

Q: How long does it take to see weight loss results

What happens after the medication ships

And while results can be impressive in the short term, the long-term picture is more complex: in one clinical study, participants regained two-thirds of their lost weight within a year of stopping treatment